Hemophilia A Clinical Trials

Find Hemophilia A Clinical Trials Near You

Tight Control of Treatment Adherence and Efficacy by Telemedicine for an Improved Personalized Management of Patients With Hemophilia

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In patients with haemophilia, close monitoring of bleeding with optimal adherence to treatment, a personalised treatment programme and the possibility of early diagnosis of haemarthrosis are essential. The TEMPO project will help advance the state of the art in optimal adherence, rigorous monitoring, and accurate and early diagnosis and management of haemarthrosis by collecting and integrating big data in order to personalise the treatment regimen for each patient, as envisaged by the current model of personalised medicine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• informed consent

• age (minimum 18 years)

• hemophilia

• having a smartphone

Locations
Other Locations
Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
RECRUITING
Milan
Contact Information
Primary
Roberta Gualtierotti, Professor
roberta.gualtierotti@unimi.it
+39 0255034072
Time Frame
Start Date: 2025-10-19
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 50
Treatments
Experimental: TEMPO
TEMPO system
No_intervention: CONTROL
No intervention
Related Therapeutic Areas
Sponsors
Leads: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

This content was sourced from clinicaltrials.gov